NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,081 | -9.4% | 20,432 | -10.3% | 0.08% | -7.2% |
| Q2 2023 | $2,298 | +145.8% | 22,772 | +124.0% | 0.08% | +130.6% |
| Q1 2023 | $935 | +0.4% | 10,168 | -1.0% | 0.04% | -5.3% |
| Q4 2022 | $931 | -99.9% | 10,266 | -8.2% | 0.04% | -9.5% |
| Q3 2022 | $850,000 | -73.7% | 11,182 | -70.8% | 0.04% | -71.4% |
| Q2 2022 | $3,236,000 | +181.4% | 38,276 | +192.0% | 0.15% | +200.0% |
| Q1 2022 | $1,150,000 | +1.3% | 13,110 | +1.0% | 0.05% | 0.0% |
| Q4 2021 | $1,135,000 | +26.8% | 12,981 | +18.6% | 0.05% | +14.0% |
| Q3 2021 | $895,000 | -3.6% | 10,946 | +7.6% | 0.04% | -4.4% |
| Q2 2021 | $928,000 | +10.6% | 10,173 | +3.6% | 0.04% | 0.0% |
| Q1 2021 | $839,000 | +67.5% | 9,820 | +85.0% | 0.04% | +50.0% |
| Q4 2020 | $501,000 | +129.8% | 5,308 | +92.6% | 0.03% | -23.1% |
| Q3 2016 | $218,000 | -80.3% | 2,756 | -79.4% | 0.04% | -79.5% |
| Q2 2016 | $1,105,000 | +303.3% | 13,396 | +382.9% | 0.19% | +265.4% |
| Q1 2015 | $274,000 | – | 2,774 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |